Stifel Financial Corp Meridian Bioscience Inc Transaction History

Stifel Financial Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$31.15 - $33.39 $294,056 - $315,201	-9,440 Reduced 37.42%	15,790 $524,000
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $829,201 - $900,314	-26,835 Reduced 51.54%	25,230 $796,000
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $6,080 - $8,112	-256 Reduced 0.49%	52,065 $1.58 Million
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $78,701 - $106,170	3,941 Added 8.15%	52,321 $1.36 Million
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $259,281 - $320,908	-14,850 Reduced 23.49%	48,380 $987,000
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $193,730 - $251,235	-11,166 Reduced 15.01%	63,230 $1.22 Million
Q2 2021 Aug 13, 2021	BUY	$18.01 - $28.32 $605,027 - $951,382	33,594 Added 82.33%	74,396 $1.65 Million
Q1 2021 May 14, 2021	BUY	$19.76 - $29.89 $174,322 - $263,689	8,822 Added 27.59%	40,802 $1.07 Million
Q4 2020 Feb 12, 2021	BUY	$15.73 - $21.66 $61,661 - $84,907	3,920 Added 13.97%	31,980 $598,000
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $379,932 - $741,064	28,060 New	28,060 $476,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.